RECURRENT UTERINE CORPUS CARCINOMA
Clinical trials for RECURRENT UTERINE CORPUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT UTERINE CORPUS CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT UTERINE CORPUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat recurrent cancers
Disease control OngoingThis early-phase trial tests two different drug combinations—olaparib plus vistusertib, or olaparib plus capivasertib—in people with recurrent endometrial, triple-negative breast, ovarian, primary peritoneal, or fallopian tube cancer. The main goal is to find the safest dose and …
Matched conditions: RECURRENT UTERINE CORPUS CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heated chemo during surgery may fight ovarian cancer return
Disease control OngoingThis early-phase trial tests whether giving heated chemotherapy directly into the abdomen during surgery can help prevent cancer from coming back in people with advanced ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants will receive the heated chemo du…
Matched conditions: RECURRENT UTERINE CORPUS CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC